Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2945)
All Articles published online
|
Oct 15, 2002 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tang ZH, Qiu WH, Wu GS, Yang XP, Zou SQ, Qiu FZ. The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma. World J Gastroenterol 2002; 8(5): 908-912 [PMID: 12378640 DOI: 10.3748/wjg.v8.i5.908] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i5/908.htm |
| Number | Citing Articles |
| 1 |
Tanja D. de Gruijl, Herbert M. Pinedo, Rik J. Scheper. Cancer Gene Therapy. 2005; : 143 doi: 10.1007/978-1-59259-785-7_10
|
| 2 |
Hemanth K. Kandikattu, Sathisha U. Venkateshaiah, Anil Mishra. Chronic Pancreatitis and the Development of Pancreatic Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(8): 1182 doi: 10.2174/1871530320666200423095700
|
| 3 |
Shu Zheng, Zuo-Xiang Xiao, Yue-Long Pan, Ming-Yong Han, Qi Dong. Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy. World Journal of Gastroenterology 2003; 9(5): 951-955 doi: 10.3748/wjg.v9.i5.951
|
| 4 |
Xiaohui Han, Jingshuai Sun, Xiaocheng Lv, Xiaoyu Tang, Yubin Zheng, Jinyun Ma, Yuan Sun. A Recombinant Oncolytic Pseudorabies Virus Expressing Interleukin-18, Interferon-Gamma and PH20 Genes Promotes Systemic Antitumor Immunity. Microorganisms 2023; 11(7): 1850 doi: 10.3390/microorganisms11071850
|
| 5 |
Zhi-Hua Feng, Quan-Chu Wang, Qing-He Nie, Zhan-Sheng Jia, Yong-Xin Zhou. DC-SIGN: Binding receptor for HCV?. World Journal of Gastroenterology 2004; 10(7): 925-929 doi: 10.3748/wjg.v10.i7.925
|
| 6 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
| 7 |
Ming-Qing Xu, Zhen-Xiang Yao. Functional changes of dendritic cells derived from allogeneic partial liver graft undergoing acute rejection in rats. World Journal of Gastroenterology 2003; 9(1): 141-147 doi: 10.3748/wjg.v9.i1.141
|
| 8 |
Mojtaba Taheri, Hossein Abdul Tehrani, Fatemeh Daliri, Mona Alibolandi, Masoud Soleimani, Alireza Shoari, Ehsan Arefian, Mohammad Ramezani. Bioengineering strategies to enhance the interleukin-18 bioactivity in the modern toolbox of cancer immunotherapy. Cytokine & Growth Factor Reviews 2024; 75: 65 doi: 10.1016/j.cytogfr.2023.09.005
|
| 9 |
Jagoda Mierzejewska, Katarzyna Węgierek-Ciura, Joanna Rossowska, Agnieszka Szczygieł, Natalia Anger-Góra, Bożena Szermer-Olearnik, Magdalena Geneja, Elżbieta Pajtasz-Piasecka, Baohui Xu. The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/7508928
|
| 10 |
Zhiqiang Li, Xiao Yu, Jens Werner, Alexandr V. Bazhin, Jan G. D’Haese. The role of interleukin-18 in pancreatitis and pancreatic cancer. Cytokine & Growth Factor Reviews 2019; 50: 1 doi: 10.1016/j.cytogfr.2019.11.001
|
| 11 |
Bing-Ya Liu, Xue-Hua Chen, Qin-Long Gu, Jian-Fang Li, Hao-Ran Yin, Zheng-Gang Zhu, Yan-Zhen Lin. Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer. World Journal of Gastroenterology 2004; 10(5): 630-633 doi: 10.3748/wjg.v10.i5.630
|
| 12 |
Cristina Fillat, Anabel Jose, Xavier Bofill-De Ros, Ana Mato-Berciano, Maria Victoria Maliandi, Luciano Sobrevals. Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems. Cancers 2011; 3(1): 368 doi: 10.3390/cancers3010368
|
| 13 |
Jean Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, Nicoletta Eliopoulos, Sebastien Talbot, Riam Shammaa, Moutih Rafei. The <i>CIt</i> Protocol: A Blueprint to Potentiate the Immunogenicity of Immunoproteasome-Reprogrammed Mesenchymal Stromal Cells. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4166327
|
| 14 |
Çiğdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Murat Serilmez, Faruk Tas. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Journal of Infection and Chemotherapy 2017; 23(4): 196 doi: 10.1016/j.jiac.2016.12.003
|
| 15 |
Ming-Qing Xu, Wei Wang, Lan Xue, Lv-Nan Yan. NF-κB activation and zinc finger protein A20 expression in mature dendritic cells derived from liver allografts undergoing acute rejection. World Journal of Gastroenterology 2003; 9(6): 1296-1301 doi: 10.3748/wjg.v9.i6.1296
|
| 16 |
Anton Deicher, Roland Andersson, Bobby Tingstedt, Gert Lindell, Monika Bauden, Daniel Ansari. Targeting dendritic cells in pancreatic ductal adenocarcinoma. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0585-0
|
| 17 |
Jin Xu, Chen Jin, Sijie Hao, Guopei Luo, Deliang Fu. Pancreatic cancer: gene therapy approaches and gene delivery systems. Expert Opinion on Biological Therapy 2010; 10(1): 73 doi: 10.1517/14712590903321454
|
| 18 |
Jean-Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, Nicoletta Eliopoulos, Sebastien Talbot, Riam Shammaa, Moutih Rafei. The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells. iScience 2022; 25(12): 105537 doi: 10.1016/j.isci.2022.105537
|
| 19 |
Jia Yang, Junjie Shangguan, Aydin Eresen, Yu Li, Jian Wang, Zhuoli Zhang. Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies. Pathology - Research and Practice 2019; 215(12): 152691 doi: 10.1016/j.prp.2019.152691
|